Antiamyloid Monoclonal Antibodies in Alzheimer's Disease, Part 2: Challenges in Dementia Care Delivery System Logistics.
Carlisle TC, Bateman JR, Yang Y, Lachner C, Stockbridge MD, Flashman LA, Chemali Z, Alzbeidi N, Pressman PS, Osibajo AM, Bobrin BD, Martinez-Menendez CJ, Teixeira AL, Daffner KR. Antiamyloid Monoclonal Antibodies in Alzheimer's Disease, Part 2: Challenges in Dementia Care Delivery System Logistics. J Neuropsychiatry Clin Neurosci. 2025; 37(4):378-384.